Skip to content
June 30, 2022

Equity.Guru

Investment information for the new generation

neuroplasticity

Algernon Pharmaceuticals (AGN.C) and Charles River Laboratories agreed to have the latter handle Algernon’s DMT pre-clinical studies for their stroke clinical research program today, according to a press release….